ArticleJapanese journal of cancer research : Gann2002

Beta-hydroxyisovalerylshikonin is a novel and potent inhibitor of protein tyrosine kinases.

Sachiko Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.